PR Newswire: news distribution, targeting and monitoring
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biotechnology Sector (CIX: MSECTOR515)
1,908.18   UNCHANGED
Streaming Delayed Price  /  Updated: 6:40 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 1879.35
Prev. Close 1908.18
Today's Range 1863.52 - 1919.46
52wk Range 1421.56 - 2058.41
Components
View All
Value % Change
Gilead Sciences, Inc.  51.94
0.00%
Amgen, Inc.  101.50
0.00%
Celgene Corp  120.24
0.00%
Biogen Idec, Inc.  210.80
0.00%
Regeneron Pharmaceuticals, Inc.  242.76
0.00%
Life Technologies Corporation  74.27
0.00%
Illumina, Inc.  71.69
0.00%
BioMarin Pharmaceuticals, Inc.  58.31
0.00%
Onyx Pharmaceuticals, Inc.  88.80
0.00%
Qiagen NV  19.62
0.00%
Top News
More News
Protalix BioTherapeutics and Brazil's Ministry of Health Enter Into Supply and Technology Transfer Agreement for UPLYSO(TM) (alfataliglicerase) in Brazil
Today 2:00 EDT
Exclusive License and Supply Agreement With Pfizer Amended to Facilitate the Technology Transfer Read More
from GlobeNewswire News Releases
Perfect Trade Setups, How to Play SLB, MDT, MDVN and GM
June 18, 2013
from Marketwired News Releases
UPDATE: Oppenheimer Initiates Coverage on Neurocrine Biosciences on Potential Elagolix Success
June 18, 2013
In a report published on Tuesday, Oppenheimer analyst David Ferreiro initiated coverage on Neurocrine Biosciences (NASDAQ: NBIX ) with a rating of Outperform and a price target of $16. In the report,... Read More
from Latest Articles from Benzinga.com
More News
More News
MannKind Will Drop Says Motley Fool
June 18, 2013
Motley Fool expects MannKind Corp.'s (Nasdaq: MNKD) stock price to retreat. Shares of the biopharmaceutical dropped 93 cents to close at $6.61.... Read More
from MarketMinute.com Stock News
Cytokinetics To Present Results
June 18, 2013
Cytokinetics Inc. (Nasdaq: CYTK) will present results from a Phase IIb clinical trial of omecamtiv mecarbil during a Hot Line Late Breaking Trials Session at the European Society of Cardiology Congress... Read More
from MarketMinute.com Stock News
Amgen (AMGN) Boosts Cytokinetics (CYTK) to 7.58%
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8428826 for the full story. Read More
from StreetInsider.com News Articles
Selling Used Laptops Is Now Easier With The Cash Out Laptop LLC. Laptop Pricing Engine
June 18, 2013
from Press Release Distribution Newswire - Submit News Online - MarketersMedia »
Bullish Two Hundred Day Moving Average Cross - EXEL
June 18, 2013
In trading on Tuesday, shares of Exelixis Inc (EXEL) crossed above their 200 day moving average of $4.78, changing hands as high as $4.82 per share. Exelixis Inc shares are currently trading up about... Read More
from Market News Video

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire